Harrow Inc has a consensus price target of $24.25, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Craig-Hallum, B. Riley Securities, and B. Riley Securities on April 11, 2024, March 22, 2024, and July 20, 2023. With an average price target of $31.67 between Craig-Hallum, B. Riley Securities, and B. Riley Securities, there's an implied 204.19% upside for Harrow Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/11/2024 | HROW | Buy Now | Harrow | $10.41 | 130.55% | Craig-Hallum | — | → $24 | Initiates | → Buy | Get Alert |
03/22/2024 | HROW | Buy Now | Harrow | $10.41 | 149.76% | B. Riley Securities | Sahil Kazmi | $30 → $26 | Maintains | Buy | Get Alert |
07/20/2023 | HROW | Buy Now | Harrow Health | $10.41 | 332.28% | B. Riley Securities | Sahil Kazmi | $42 → $45 | Maintains | Buy | Get Alert |
04/17/2023 | HROW | Buy Now | Harrow Health | $10.41 | 255.43% | Lake Street | Brooks O'Neil | $24 → $37 | Maintains | Buy | Get Alert |
09/08/2022 | HROW | Buy Now | Harrow Health | $10.41 | 63.3% | B. Riley Securities | Sahil Kazmi | → $17 | Reinstates | → Buy | Get Alert |
05/20/2022 | HROW | Buy Now | Harrow Health | $10.41 | 92.12% | B. Riley Securities | Justin Walsh | $17 → $20 | Maintains | Buy | Get Alert |
07/02/2021 | HROW | Buy Now | Harrow Health | $10.41 | 36.89% | Ladenburg Thalmann | Jeffrey Cohen | — | Initiates | → Buy | Get Alert |
The latest price target for Harrow (NASDAQ: HROW) was reported by Craig-Hallum on April 11, 2024. The analyst firm set a price target for $24.00 expecting HROW to rise to within 12 months (a possible 132.56% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Harrow (NASDAQ: HROW) was provided by Craig-Hallum, and Harrow initiated their buy rating.
There is no last upgrade for Harrow.
There is no last downgrade for Harrow.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harrow, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harrow was filed on April 11, 2024 so you should expect the next rating to be made available sometime around April 11, 2025.
While ratings are subjective and will change, the latest Harrow (HROW) rating was a initiated with a price target of $0.00 to $24.00. The current price Harrow (HROW) is trading at is $10.32, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.